LEVOLEUCOVORIN CALCIUM

LEVOLEUCOVORIN CALCIUM was reported 3809 times

LEVOLEUCOVORIN CALCIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 METASTASES TO PERINEUM 3 0.2727
1 ANAESTHESIA DOLOROSA 1 0.1429
2 SCIATIC NERVE PALSY 9 0.1098
3 TRANSIENT APHASIA 13 0.0992
4 DUODENAL VARICES 2 0.0833
5 DIVERSION COLITIS 2 0.0606
6 STOMAL VARICES 4 0.0488
7 ANAL EROSION 5 0.0455
8 ACRAL PEELING SKIN SYNDROME 1 0.0435
9 TUMOUR PERFORATION 12 0.0377
10 CATHETER SITE ULCER 1 0.0357
11 ARTERIOENTERIC FISTULA 1 0.0312
12 PULMONARY FISTULA 3 0.0309
13 HEALTH ASSESSMENT QUESTIONNAIRE SCORE INCREASED 3 0.0288
14 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 5 0.0282
15 STOMA SITE ULCER 5 0.0282
16 MEDICAL DEVICE SITE INFLAMMATION 2 0.0278
17 FAILED INDUCTION OF LABOUR 5 0.0258
18 BENIGN SMALL INTESTINAL NEOPLASM 1 0.0256
19 PERIPHERAL VEIN THROMBOSIS 6 0.0251
20 AORTIC WALL HYPERTROPHY 1 0.0244
21 VIRAL SKIN INFECTION 3 0.0242
22 RECTAL CANCER RECURRENT 2 0.0235
23 TUMOUR OBSTRUCTION 2 0.0230
24 THROMBOPHLEBITIS MIGRANS 7 0.0206
25 GLOMERULAR VASCULAR DISORDER 3 0.0200
26 CENTRAL NERVOUS SYSTEM NEOPLASM 3 0.0186
27 FAILURE TO ANASTOMOSE 2 0.0182
28 INTESTINAL METASTASIS 6 0.0165
29 CHOLANGITIS INFECTIVE 4 0.0150
30 AZOTAEMIA 60 0.0150
31 ORAL DYSAESTHESIA 3 0.0146
32 COLON CANCER RECURRENT 4 0.0145
33 CHOLINERGIC SYNDROME 9 0.0141
34 PORTAL VENOUS GAS 5 0.0138
35 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 2 0.0135
36 IMMUNE-MEDIATED ENDOCRINOPATHY 2 0.0133
37 INFECTIOUS PERITONITIS 9 0.0133
38 GALLBLADDER RUPTURE 6 0.0130
39 URETHRAL DISORDER 6 0.0127
40 AORTIC DISSECTION RUPTURE 1 0.0127
41 ANASTOMOTIC FISTULA 1 0.0127
42 METASTASES TO OVARY 4 0.0125
43 CUTANEOUS SYMPTOM 8 0.0117
44 SCABIES 2 0.0117
45 PARONYCHIA 51 0.0116
46 DERMATITIS ACNEIFORM 70 0.0115
47 HEART FAILURE WITH REDUCED EJECTION FRACTION 6 0.0112
48 INSULIN AUTOIMMUNE SYNDROME 4 0.0112
49 IN VITRO FERTILISATION 2 0.0110
50 AMOEBIC COLITIS 1 0.0110
51 PROCTECTOMY 3 0.0109
52 STOMAL HERNIA 4 0.0109
53 DUODENAL STENOSIS 5 0.0103
54 PROTEIN-LOSING GASTROENTEROPATHY 5 0.0101
55 FIBROMA 9 0.0098
56 IMMUNE-MEDIATED RENAL DISORDER 4 0.0097
57 COLONY STIMULATING FACTOR THERAPY 2 0.0097
58 TRANSFERRIN SATURATION DECREASED 4 0.0094
59 RECTAL PERFORATION 5 0.0093
60 GASTRIC VARICES HAEMORRHAGE 3 0.0091
61 BRONCHOSTENOSIS 5 0.0091
62 FUNGAL FOOT INFECTION 4 0.0091
63 ILEAL PERFORATION 6 0.0090
64 HYPERAMMONAEMIA 45 0.0090
65 ANASTOMOTIC COMPLICATION 3 0.0087
66 RECTAL CANCER METASTATIC 3 0.0086
67 ANAPHYLACTOID SHOCK 4 0.0085
68 INFUSION RELATED HYPERSENSITIVITY REACTION 5 0.0083
69 STOMA SITE ABSCESS 2 0.0082
70 BRONCHITIS BACTERIAL 6 0.0079
71 BAND SENSATION 10 0.0079
72 CARBOHYDRATE ANTIGEN 19-9 INCREASED 4 0.0076
73 DYSENTERY 14 0.0075
74 ATHEROEMBOLISM 1 0.0074
75 CATHETER SITE THROMBOSIS 2 0.0073
76 HAEMOBILIA 3 0.0072
77 ANASTOMOTIC LEAK 5 0.0072
78 PERINEAL PAIN 5 0.0070
79 HAEMATOMA INFECTION 4 0.0069
80 CAMPYLOBACTER GASTROENTERITIS 4 0.0067
81 CHOLANGITIS 41 0.0066
82 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 3 0.0065
83 BILIARY FISTULA 1 0.0065
84 DISABILITY ASSESSMENT SCALE SCORE INCREASED 2 0.0065
85 PULMONARY ARTERY THROMBOSIS 5 0.0065
86 GASTROINTESTINAL PERFORATION 27 0.0065
87 GRANULOCYTE COUNT DECREASED 12 0.0065
88 XEROSIS 8 0.0065
89 COOMBS DIRECT TEST POSITIVE 2 0.0064
90 METASTASES TO PERITONEUM 16 0.0063
91 KLEBSIELLA SEPSIS 7 0.0062
92 DUODENAL PERFORATION 6 0.0061
93 GASTROENTERITIS RADIATION 2 0.0061
94 GASTRIC MUCOSA ERYTHEMA 2 0.0060
95 VASCULAR DEVICE OCCLUSION 2 0.0059
96 SMALL INTESTINAL PERFORATION 11 0.0059
97 VERTEBRAL LESION 3 0.0058
98 FULMINANT TYPE 1 DIABETES MELLITUS 6 0.0058
99 EYE SYMPTOM 2 0.0056
100 HERPES ZOSTER MENINGOENCEPHALITIS 2 0.0056
101 HYPOALBUMINAEMIA 43 0.0055
102 XANTHOPSIA 2 0.0054
103 COLONIC FISTULA 3 0.0053
104 IMMUNE-MEDIATED PANCREATITIS 2 0.0052
105 FIXED ERUPTION 9 0.0052
106 MALIGNANT ASCITES 4 0.0052
107 STOMA SITE EXTRAVASATION 2 0.0052
108 ADMINISTRATION RELATED REACTION 1 0.0051
109 PRINZMETAL ANGINA 5 0.0050
110 CARDIAC NEOPLASM UNSPECIFIED 1 0.0050
111 ACUTE CHOLECYSTITIS NECROTIC 1 0.0050
112 LARGE INTESTINE PERFORATION 34 0.0049
113 ORAL MUCOSA EROSION 6 0.0049
114 MONOCYTOSIS 3 0.0048
115 CAMPYLOBACTER INFECTION 4 0.0048
116 ADRENOMEGALY 1 0.0048
117 FISTULA OF SMALL INTESTINE 2 0.0048
118 ARTERITIS 3 0.0047
119 ARTERIAL THROMBOSIS 9 0.0047
120 PAPILLOEDEMA 21 0.0046
121 ENTEROCOLITIS 26 0.0045
122 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 2 0.0045
123 HEPATIC ATROPHY 2 0.0045
124 LOCALISED INTRAABDOMINAL FLUID COLLECTION 2 0.0044
125 IMMUNE-MEDIATED HYPOPHYSITIS 2 0.0044
126 CONDUCTION DISORDER 8 0.0044
127 COLON CANCER METASTATIC 7 0.0043
128 PYOGENIC GRANULOMA 2 0.0043
129 PERIPHERAL SENSORY NEUROPATHY 25 0.0043
130 IMMUNE-MEDIATED NEPHRITIS 2 0.0043
131 MICROANGIOPATHY 4 0.0043
132 PULMONARY TOXICITY 30 0.0042
133 PNEUMATOSIS INTESTINALIS 12 0.0042
134 CANCER FATIGUE 1 0.0042
135 PERIPHERAL ISCHAEMIA 17 0.0042
136 CUTANEOUS LUPUS ERYTHEMATOSUS 8 0.0041
137 RESPIRATORY TRACT OEDEMA 3 0.0040
138 HYPERTRANSAMINASAEMIA 28 0.0040
139 HYPERCREATININAEMIA 2 0.0040
140 CHOLANGITIS ACUTE 3 0.0040
141 HYPERAESTHESIA TEETH 5 0.0040
142 ANGLE CLOSURE GLAUCOMA 10 0.0039
143 UTERINE DISORDER 9 0.0039
144 IMMUNE-MEDIATED LUNG DISEASE 7 0.0038
145 ABDOMINAL WALL HAEMORRHAGE 1 0.0038
146 METASTASES TO PLEURA 4 0.0038
147 MYELOSUPPRESSION 136 0.0038
148 BLOOD CHOLINESTERASE DECREASED 1 0.0036
149 SEROUS RETINAL DETACHMENT 3 0.0036
150 MECHANICAL ILEUS 2 0.0035
151 ACUTE POLYNEUROPATHY 1 0.0035
152 NEUTROPHIL COUNT DECREASED 142 0.0035
153 CATHETER SITE CELLULITIS 1 0.0034
154 PNEUMOMEDIASTINUM 6 0.0033
155 PROTEIN URINE 3 0.0033
156 HYPERTHERMIA 25 0.0033
157 ASPERGILLUS TEST POSITIVE 1 0.0032
158 PORTAL HYPERTENSION 10 0.0032
159 BILIARY TRACT INFECTION 2 0.0032
160 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 4 0.0032
161 PSOAS ABSCESS 2 0.0032
162 MUSCLE ABSCESS 2 0.0032
163 LYMPHADENECTOMY 3 0.0031
164 NEPHROTIC SYNDROME 21 0.0031
165 IMMUNE THROMBOCYTOPENIA 14 0.0031
166 GASTROINTESTINAL MUCOSAL DISORDER 2 0.0031
167 BLOOD ALBUMIN DECREASED 24 0.0030
168 MUCOSAL DISORDER 3 0.0030
169 ILEAL ULCER 3 0.0030
170 FEMALE GENITAL TRACT FISTULA 5 0.0029
171 AORTITIS 2 0.0029
172 SOFT TISSUE NECROSIS 2 0.0029
173 COLONIC STENOSIS 1 0.0029
174 LYMPHANGIOSIS CARCINOMATOSA 3 0.0029
175 HYPOMAGNESAEMIA 40 0.0029
176 NUTRITIONAL CONDITION ABNORMAL 2 0.0029
177 TYPE I HYPERSENSITIVITY 10 0.0028
178 BURNING SENSATION MUCOSAL 1 0.0028
179 ASTERIXIS 3 0.0028
180 EPIGASTRIC DISCOMFORT 11 0.0028
181 GASTROINTESTINAL NECROSIS 8 0.0027
182 ARTERIOSPASM CORONARY 11 0.0027
183 ACUTE ABDOMEN 4 0.0027
184 AORTIC ARTERIOSCLEROSIS 7 0.0027
185 IMMUNE-MEDIATED ENTEROCOLITIS 10 0.0027
186 ADENOCARCINOMA OF COLON 5 0.0027
187 IMMUNE-MEDIATED HYPOTHYROIDISM 3 0.0027
188 RENAL COLIC 6 0.0027
189 ALKALOSIS 1 0.0026
190 MACROCYTOSIS 3 0.0026
191 AORTIC RUPTURE 1 0.0026
192 RESTRICTIVE PULMONARY DISEASE 3 0.0026
193 CLONUS 7 0.0026
194 INTERSTITIAL LUNG DISEASE 123 0.0025
195 GENE MUTATION 5 0.0025
196 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 2 0.0025
197 LYMPHOCYTE STIMULATION TEST POSITIVE 2 0.0025
198 PERFORATION 2 0.0025
199 DIARRHOEA HAEMORRHAGIC 23 0.0025
200 ANAPHYLACTOID REACTION 10 0.0024
201 BLOOD PRESSURE SYSTOLIC ABNORMAL 6 0.0024
202 PERITONSILLAR ABSCESS 2 0.0024
203 WOUND DEHISCENCE 8 0.0024
204 COLON CANCER 35 0.0023
205 DERMATITIS BULLOUS 17 0.0023
206 HYPERAMMONAEMIC ENCEPHALOPATHY 4 0.0023
207 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 2 0.0023
208 ENTEROCUTANEOUS FISTULA 2 0.0023
209 GASTROINTESTINAL OEDEMA 4 0.0023
210 ILEUS PARALYTIC 10 0.0022
211 HYPERBILIRUBINAEMIA 23 0.0022
212 INTESTINAL ISCHAEMIA 12 0.0022
213 SKIN TEST POSITIVE 2 0.0021
214 FORCED EXPIRATORY VOLUME DECREASED 6 0.0021
215 CARCINOEMBRYONIC ANTIGEN INCREASED 4 0.0021
216 THROMBOTIC MICROANGIOPATHY 20 0.0021
217 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
218 VENOUS THROMBOSIS 8 0.0020
219 VULVOVAGINAL DISCOMFORT 9 0.0020
220 ARTERIOVENOUS FISTULA 1 0.0020
221 VENOOCCLUSIVE LIVER DISEASE 10 0.0020
222 EPICONDYLITIS 3 0.0020
223 IMMUNE-MEDIATED DERMATITIS 2 0.0020
224 MUCOSAL ULCERATION 2 0.0020
225 VASCULAR DEVICE INFECTION 9 0.0020
226 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
227 IMMUNE-MEDIATED HEPATITIS 4 0.0020
228 AORTIC VALVE CALCIFICATION 1 0.0019
229 METASTASES TO SKIN 2 0.0019
230 SUBILEUS 4 0.0019
231 URETEROLITHIASIS 2 0.0019
232 TUMOUR NECROSIS 2 0.0019
233 NEUTROPENIA 257 0.0019
234 LEUKOENCEPHALOPATHY 7 0.0019
235 METASTASES TO LIVER 33 0.0019
236 EXTRASYSTOLES 13 0.0019
237 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
238 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
239 GASTRIC PERFORATION 5 0.0018
240 CEREBELLAR SYNDROME 4 0.0018
241 ANAPHYLACTIC SHOCK 47 0.0018
242 ABDOMINAL ABSCESS 8 0.0018
243 BLOOD PH INCREASED 1 0.0018
244 LARGE INTESTINAL HAEMORRHAGE 4 0.0018
245 MALIGNANT PLEURAL EFFUSION 3 0.0018
246 SKIN TOXICITY 10 0.0018
247 PETIT MAL EPILEPSY 9 0.0018
248 METASTASES TO MENINGES 4 0.0018
249 DUODENAL ULCER HAEMORRHAGE 5 0.0017
250 PALMAR ERYTHEMA 2 0.0017
251 GRANULOMA 6 0.0017
252 MUCOSAL INFLAMMATION 44 0.0017
253 NEUROPATHY PERIPHERAL 159 0.0017
254 ONYCHOMADESIS 7 0.0017
255 METABOLIC ENCEPHALOPATHY 5 0.0017
256 EMBOLISM ARTERIAL 2 0.0017
257 FEBRILE NEUTROPENIA 110 0.0017
258 VARICES OESOPHAGEAL 5 0.0017
259 MALIGNANT NEOPLASM PROGRESSION 169 0.0016
260 FEBRILE BONE MARROW APLASIA 7 0.0016
261 HEPATIC CYTOLYSIS 21 0.0016
262 TETANY 3 0.0016
263 METASTASES TO LYMPH NODES 11 0.0016
264 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
265 KETOACIDOSIS 12 0.0016
266 BACILLUS INFECTION 1 0.0016
267 RASH MACULO-PAPULAR 35 0.0016
268 PHYSICAL DECONDITIONING 4 0.0016
269 ABDOMINAL WALL ABSCESS 1 0.0015
270 LIVER ABSCESS 5 0.0015
271 IMMUNE-MEDIATED HEPATIC DISORDER 3 0.0015
272 HYPOVENTILATION 5 0.0015
273 DRUG CLEARANCE DECREASED 2 0.0015
274 ENCEPHALITIS AUTOIMMUNE 2 0.0015
275 MENINGITIS 10 0.0015
276 SIALOADENITIS 2 0.0015
277 URETERIC OBSTRUCTION 2 0.0015
278 HICCUPS 12 0.0015
279 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
280 THERAPEUTIC PROCEDURE 2 0.0014
281 NECROTISING FASCIITIS 5 0.0014
282 APPLICATION SITE ULCER 1 0.0014
283 PANCREATIC CARCINOMA METASTATIC 4 0.0014
284 TUMOUR HAEMORRHAGE 4 0.0014
285 PELVIC VENOUS THROMBOSIS 2 0.0014
286 CHYLOTHORAX 1 0.0014
287 BRAIN CONTUSION 1 0.0014
288 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 13 0.0014
289 ASCITES 40 0.0014
290 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
291 PSEUDOMEMBRANOUS COLITIS 3 0.0013
292 LARGE INTESTINAL OBSTRUCTION 3 0.0013
293 PELVIC INFLAMMATORY DISEASE 2 0.0013
294 THYROIDITIS 4 0.0013
295 SENSITIVITY TO WEATHER CHANGE 7 0.0013
296 SUSPECTED OFF LABEL USE 6 0.0013
297 ACUTE CORONARY SYNDROME 11 0.0013
298 PNEUMONIA PSEUDOMONAL 2 0.0013
299 RECTAL CANCER 4 0.0013
300 ARTERIAL RUPTURE 1 0.0013
301 STOMA SITE HAEMORRHAGE 2 0.0013
302 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
303 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
304 VASCULAR RUPTURE 2 0.0013
305 HEPATIC ENCEPHALOPATHY 12 0.0013
306 LEUKOPENIA 64 0.0013
307 DUODENAL ULCER 9 0.0013
308 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
309 MELAENA 28 0.0013
310 HEPATITIS B REACTIVATION 4 0.0013
311 TUMOUR MARKER INCREASED 6 0.0012
312 TUMOUR LYSIS SYNDROME 11 0.0012
313 SKIN EROSION 4 0.0012
314 DRUG ERUPTION 22 0.0012
315 FOLLICULITIS 13 0.0012
316 IMMUNE-MEDIATED MYOCARDITIS 2 0.0012
317 PORTAL VEIN THROMBOSIS 4 0.0012
318 RASH PUSTULAR 9 0.0012
319 EXTRAVASATION 5 0.0012
320 ILEUS 15 0.0012
321 ANEURYSM 6 0.0012
322 ANTIBODY TEST POSITIVE 2 0.0012
323 VENA CAVA THROMBOSIS 2 0.0012
324 CARDIAC FAILURE ACUTE 8 0.0012
325 OSTEITIS 3 0.0012
326 RETINAL ARTERY OCCLUSION 3 0.0012
327 URINARY TRACT INFECTION BACTERIAL 3 0.0012
328 COLITIS ISCHAEMIC 8 0.0012
329 THROMBOCYTOPENIA 132 0.0012
330 ANURIA 10 0.0012
331 STOMATITIS 70 0.0012
332 VASCULAR PSEUDOANEURYSM 2 0.0011
333 CEREBRAL INFARCTION 28 0.0011
334 THROMBOTIC THROMBOCYTOPENIC PURPURA 4 0.0011
335 METASTASES TO LUNG 13 0.0011
336 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0011
337 HYPOCALCAEMIA 21 0.0011
338 FAECALOMA 6 0.0011
339 ANEURYSM RUPTURED 1 0.0011
340 COLOUR BLINDNESS 1 0.0011
341 PERFORMANCE STATUS DECREASED 5 0.0011
342 VAGINAL INFECTION 5 0.0011
343 PERITONITIS 22 0.0011
344 BRAIN STEM HAEMORRHAGE 1 0.0011
345 OESOPHAGEAL STENOSIS 3 0.0011
346 GRANULOCYTOPENIA 6 0.0011
347 PROTEINURIA 20 0.0011
348 TONGUE OEDEMA 4 0.0010
349 HEART VALVE INCOMPETENCE 3 0.0010
350 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
351 HYPERTRIGLYCERIDAEMIA 6 0.0010
352 HYPERAEMIA 2 0.0010
353 CARDIOTOXICITY 9 0.0010
354 OESOPHAGITIS 11 0.0010
355 POLYNEUROPATHY 12 0.0010
356 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
357 HEPATITIS CHOLESTATIC 6 0.0010
358 SKIN DISORDER 33 0.0010
359 SUDDEN HEARING LOSS 2 0.0010
360 BUTTERFLY RASH 1 0.0010
361 INTESTINAL OBSTRUCTION 37 0.0010
362 DYSAESTHESIA 3 0.0010
363 DEVICE RELATED INFECTION 15 0.0010
364 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
365 CACHEXIA 5 0.0010
366 PNEUMONIA ASPIRATION 24 0.0010
367 LUNG ABSCESS 2 0.0010
368 HYPOKALAEMIA 44 0.0010
369 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 22 0.0009
370 SPLENOMEGALY 11 0.0009
371 ANAL FISTULA 5 0.0009
372 PURULENT DISCHARGE 4 0.0009
373 PULMONARY TUBERCULOSIS 4 0.0009
374 ABSCESS INTESTINAL 2 0.0009
375 HEPATIC LESION 4 0.0009
376 OESOPHAGEAL VARICES HAEMORRHAGE 2 0.0009
377 DEAFNESS NEUROSENSORY 3 0.0009
378 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
379 GASTRIC ULCER HAEMORRHAGE 5 0.0009
380 CARDIAC HYPERTROPHY 1 0.0009
381 SMALL INTESTINE CARCINOMA 2 0.0009
382 ADENOCARCINOMA 2 0.0009
383 CATHETER SITE DISCHARGE 1 0.0009
384 TONGUE ULCERATION 3 0.0009
385 APLASIA PURE RED CELL 3 0.0009
386 PNEUMONIA BACTERIAL 8 0.0009
387 ACUTE PRERENAL FAILURE 1 0.0009
388 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
389 WHITE BLOOD CELL COUNT DECREASED 93 0.0009
390 PULMONARY INFARCTION 2 0.0008
391 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
392 COLORECTAL CANCER METASTATIC 2 0.0008
393 EMBOLISM 7 0.0008
394 LACUNAR INFARCTION 2 0.0008
395 HYPOVOLAEMIC SHOCK 4 0.0008
396 BILE DUCT STENOSIS 1 0.0008
397 PYODERMA GANGRENOSUM 3 0.0008
398 PANNICULITIS 2 0.0008
399 DECREASED APPETITE 191 0.0008
400 BODY TEMPERATURE DECREASED 8 0.0008
401 HYPERTENSIVE CRISIS 9 0.0008
402 CARDIAC DYSFUNCTION 3 0.0008
403 HYDRONEPHROSIS 6 0.0008
404 HYPERKALAEMIA 28 0.0008
405 DERMATOMYOSITIS 2 0.0008
406 APPENDICITIS PERFORATED 2 0.0008
407 MYOCARDITIS 9 0.0008
408 ABDOMINAL INFECTION 2 0.0008
409 CANCER PAIN 2 0.0008
410 HEAVY MENSTRUAL BLEEDING 7 0.0008
411 APPLICATION SITE EROSION 1 0.0008
412 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
413 CATHETER SITE PAIN 2 0.0008
414 INFUSION RELATED REACTION 51 0.0008
415 ACCIDENT 9 0.0008
416 OESOPHAGEAL CANDIDIASIS 3 0.0008
417 LARYNGOSPASM 2 0.0007
418 ANAL ABSCESS 4 0.0007
419 CYTOPENIA 9 0.0007
420 RENAL TUBULAR DISORDER 2 0.0007
421 HYPERPYREXIA 3 0.0007
422 AUDITORY DISORDER 1 0.0007
423 POOR PERIPHERAL CIRCULATION 3 0.0007
424 NEUTROPENIC SEPSIS 5 0.0007
425 SALIVARY HYPERSECRETION 7 0.0007
426 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
427 HEPATIC FUNCTION ABNORMAL 26 0.0007
428 METASTATIC NEOPLASM 3 0.0007
429 ONYCHOMYCOSIS 3 0.0007
430 CARDIAC FIBRILLATION 1 0.0007
431 PURPURA 6 0.0007
432 SUNBURN 5 0.0007
433 WEIGHT FLUCTUATION 7 0.0007
434 MIXED LIVER INJURY 2 0.0007
435 HEPATITIS 17 0.0007
436 ADHESION 1 0.0007
437 PLATELET COUNT ABNORMAL 4 0.0007
438 EMBOLISM VENOUS 2 0.0007
439 KERATITIS 2 0.0007
440 ANAEMIA 125 0.0007
441 DYSCHEZIA 2 0.0007
442 FACE OEDEMA 11 0.0007
443 LARYNGEAL OEDEMA 4 0.0006
444 TRANSAMINASES INCREASED 14 0.0006
445 BILE DUCT STONE 2 0.0006
446 ENTERITIS 4 0.0006
447 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
448 METASTASES TO CENTRAL NERVOUS SYSTEM 8 0.0006
449 RESPIRATORY DISTRESS 17 0.0006
450 THROMBOSIS IN DEVICE 2 0.0006
451 PLATELET COUNT DECREASED 65 0.0006
452 HYPERVOLAEMIA 3 0.0006
453 MUCOUS STOOLS 3 0.0006
454 SPINAL COMPRESSION FRACTURE 5 0.0006
455 POSTOPERATIVE WOUND INFECTION 4 0.0006
456 TOXIC ENCEPHALOPATHY 3 0.0006
457 CEREBELLAR INFARCTION 1 0.0006
458 AMMONIA INCREASED 3 0.0006
459 COLORECTAL CANCER 28 0.0006
460 BLADDER NEOPLASM 1 0.0006
461 BRONCHOPNEUMONIA 2 0.0006
462 HEPATIC FIBROSIS 2 0.0006
463 EJECTION FRACTION DECREASED 9 0.0006
464 GASTRIC ULCER 11 0.0006
465 PYELONEPHRITIS 5 0.0006
466 ADRENAL INSUFFICIENCY 7 0.0006
467 PNEUMOTHORAX 9 0.0006
468 JAUNDICE CHOLESTATIC 2 0.0006
469 LYMPHOPENIA 8 0.0006
470 FACIAL PARESIS 2 0.0006
471 FIBRIN D DIMER INCREASED 2 0.0006
472 OROPHARYNGEAL DISCOMFORT 5 0.0006
473 OEDEMA 30 0.0006
474 LEUKOCYTOSIS 10 0.0006
475 ORAL DISORDER 4 0.0005
476 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
477 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
478 PULMONARY MASS 8 0.0005
479 BLOOD CHOLESTEROL DECREASED 1 0.0005
480 MALNUTRITION 6 0.0005
481 BLOOD CALCIUM DECREASED 6 0.0005
482 CHOLECYSTITIS ACUTE 3 0.0005
483 SEPTIC SHOCK 23 0.0005
484 GENERALISED ERYTHEMA 3 0.0005
485 NEUTROPHILIA 3 0.0005
486 HAEMATOTOXICITY 5 0.0005
487 SCAB 6 0.0005
488 TROPONIN INCREASED 4 0.0005
489 HAEMOLYSIS 4 0.0005
490 STRESS CARDIOMYOPATHY 3 0.0005
491 APHTHOUS ULCER 4 0.0005
492 DISEASE PROGRESSION 61 0.0005
493 VASCULITIS 6 0.0005
494 PELVIC FRACTURE 4 0.0005
495 NEUROTOXICITY 9 0.0005
496 HAEMATEMESIS 13 0.0005
497 CELL DEATH 1 0.0005
498 SKIN ULCER 13 0.0005
499 CANDIDIASIS 2 0.0005
500 HEPATIC FAILURE 15 0.0005
501 DEEP VEIN THROMBOSIS 32 0.0005
502 BLOOD CREATININE INCREASED 32 0.0005
503 NEOPLASM PROGRESSION 17 0.0005
504 CHOLANGITIS SCLEROSING 1 0.0005
505 CAPILLARY LEAK SYNDROME 1 0.0005
506 AORTIC DISSECTION 2 0.0005
507 CONGESTIVE CARDIOMYOPATHY 2 0.0005
508 PETECHIAE 5 0.0005
509 SECRETION DISCHARGE 6 0.0005
510 DRUG-INDUCED LIVER INJURY 15 0.0005
511 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
512 CHOLESTASIS 9 0.0005
513 ANAEMIA MACROCYTIC 1 0.0005
514 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
515 URINE OUTPUT DECREASED 4 0.0005
516 BLOOD CALCIUM INCREASED 4 0.0005
517 GASTRITIS 12 0.0005
518 TOOTH FRACTURE 5 0.0005
519 VENTRICULAR FIBRILLATION 5 0.0004
520 FULL BLOOD COUNT DECREASED 9 0.0004
521 INTESTINAL PERFORATION 5 0.0004
522 CHRONIC GASTRITIS 1 0.0004
523 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
524 RESPIRATORY TRACT CONGESTION 7 0.0004
525 RENAL IMPAIRMENT 37 0.0004
526 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
527 HYPOTHYROIDISM 14 0.0004
528 SHOCK 10 0.0004
529 DIVERTICULITIS 12 0.0004
530 DERMATITIS 9 0.0004
531 ERYTHEMA MULTIFORME 4 0.0004
532 DEFAECATION URGENCY 3 0.0004
533 MOUTH ULCERATION 9 0.0004
534 DEVICE OCCLUSION 6 0.0004
535 SEPSIS 47 0.0004
536 CHOLECYSTITIS 5 0.0004
537 PYREXIA 145 0.0004
538 RECTAL HAEMORRHAGE 18 0.0004
539 SUBCUTANEOUS ABSCESS 2 0.0004
540 SWOLLEN TONGUE 13 0.0004
541 HUMERUS FRACTURE 2 0.0004
542 FAECES SOFT 3 0.0004
543 EAR PAIN 8 0.0004
544 ENCEPHALOPATHY 10 0.0004
545 METABOLIC ACIDOSIS 13 0.0004
546 GENERAL PHYSICAL HEALTH DETERIORATION 47 0.0004
547 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
548 HYPERNATRAEMIA 2 0.0004
549 ERYSIPELAS 2 0.0004
550 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
551 TASTE DISORDER 8 0.0004
552 DIARRHOEA 254 0.0004
553 ISCHAEMIC STROKE 7 0.0004
554 FEMORAL NECK FRACTURE 2 0.0004
555 TRISMUS 2 0.0004
556 NAUSEA 303 0.0004
557 VOMITING 179 0.0004
558 SUDDEN DEATH 4 0.0004
559 ULCER 6 0.0004
560 ABSCESS 6 0.0004
561 ATRIAL FLUTTER 3 0.0004
562 ASTHENIA 141 0.0004
563 ABDOMINAL MASS 1 0.0004
564 POOR QUALITY SLEEP 8 0.0004
565 BLOOD SODIUM INCREASED 1 0.0004
566 FRACTURE 7 0.0004
567 CHEILITIS 2 0.0004
568 FAECES DISCOLOURED 8 0.0004
569 ABDOMINAL RIGIDITY 1 0.0004
570 PULMONARY EMBOLISM 35 0.0004
571 NORMAL NEWBORN 2 0.0004
572 GINGIVAL BLEEDING 5 0.0004
573 WOUND INFECTION 4 0.0004
574 CHOKING SENSATION 2 0.0004
575 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
576 SKIN FISSURES 7 0.0004
577 ANAL HAEMORRHAGE 1 0.0004
578 ACUTE PULMONARY OEDEMA 2 0.0004
579 HYPONATRAEMIA 20 0.0004
580 CEREBRAL THROMBOSIS 1 0.0004
581 CYTOKINE RELEASE SYNDROME 7 0.0003
582 BLOOD MAGNESIUM DECREASED 3 0.0003
583 MULTI-ORGAN FAILURE 6 0.0003
584 MOUTH SWELLING 2 0.0003
585 ACUTE KIDNEY INJURY 53 0.0003
586 DYSARTHRIA 13 0.0003
587 FEEDING DISORDER 7 0.0003
588 ANAPHYLACTIC REACTION 19 0.0003
589 SPINAL OSTEOARTHRITIS 3 0.0003
590 CARDIOMYOPATHY 5 0.0003
591 BACTERAEMIA 4 0.0003
592 PARAESTHESIA 53 0.0003
593 ODYNOPHAGIA 2 0.0003
594 HAEMOLYTIC ANAEMIA 3 0.0003
595 ATYPICAL PNEUMONIA 1 0.0003
596 BLOOD PRESSURE FLUCTUATION 8 0.0003
597 HEPATITIS B 2 0.0003
598 HAEMOGLOBIN DECREASED 34 0.0003
599 PALLOR 9 0.0003
600 HERPES ZOSTER 19 0.0003
601 PNEUMONITIS 9 0.0003
602 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
603 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
604 EPILEPSY 10 0.0003
605 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
606 PANCYTOPENIA 18 0.0003
607 AGEUSIA 8 0.0003
608 OXYGEN SATURATION DECREASED 18 0.0003
609 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
610 OFF LABEL USE 280 0.0003
611 ABDOMINAL ADHESIONS 1 0.0003
612 LIVER DISORDER 14 0.0003
613 DISEASE RECURRENCE 15 0.0003
614 BLADDER PAIN 1 0.0003
615 HYPOXIA 11 0.0003
616 RASH PAPULAR 7 0.0003
617 ACUTE RESPIRATORY FAILURE 6 0.0003
618 DYSGEUSIA 23 0.0003
619 LACTIC ACIDOSIS 10 0.0003
620 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
621 PRODUCT PREPARATION ISSUE 2 0.0003
622 VENTRICULAR TACHYCARDIA 5 0.0003
623 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
624 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
625 SKIN MASS 2 0.0003
626 CARDIAC FAILURE 24 0.0003
627 PRODUCT ADMINISTRATION ERROR 6 0.0003
628 BRONCHIECTASIS 2 0.0003
629 OEDEMA PERIPHERAL 36 0.0003
630 BONE MARROW FAILURE 6 0.0003
631 COMA 14 0.0003
632 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
633 INFARCTION 2 0.0003
634 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
635 ONYCHOCLASIS 2 0.0003
636 POOR VENOUS ACCESS 3 0.0003
637 VENTRICULAR EXTRASYSTOLES 3 0.0003
638 ORAL DISCOMFORT 4 0.0003
639 DEHYDRATION 38 0.0003
640 BRONCHIOLITIS 1 0.0003
641 BRADYCARDIA 15 0.0003
642 SINUS TACHYCARDIA 4 0.0003
643 METASTASIS 2 0.0003
644 CARDIOGENIC SHOCK 4 0.0003
645 SKIN LACERATION 3 0.0003
646 C-REACTIVE PROTEIN INCREASED 10 0.0003
647 MOUTH HAEMORRHAGE 2 0.0003
648 AMYLASE INCREASED 1 0.0003
649 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
650 HYPOPHOSPHATAEMIA 2 0.0003
651 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
652 HYPOGLYCAEMIA 13 0.0003
653 CATHETER SITE INFECTION 1 0.0003
654 HAEMATURIA 9 0.0003
655 CLAVICLE FRACTURE 1 0.0003
656 PULMONARY FIBROSIS 5 0.0003
657 BLOOD BILIRUBIN INCREASED 7 0.0003
658 ELECTROLYTE IMBALANCE 3 0.0003
659 THERAPY PARTIAL RESPONDER 4 0.0003
660 HAEMORRHOIDS 5 0.0003
661 BLOOD PRESSURE DECREASED 17 0.0003
662 TORSADE DE POINTES 2 0.0003
663 COVID-19 PNEUMONIA 3 0.0003
664 HAEMATOCHEZIA 14 0.0003
665 BLEPHARITIS 1 0.0002
666 MALAISE 109 0.0002
667 SHOCK HAEMORRHAGIC 2 0.0002
668 ABDOMINAL PAIN 57 0.0002
669 FEELING HOT 15 0.0002
670 METASTASES TO BONE 4 0.0002
671 ERYTHEMA 50 0.0002
672 OSTEONECROSIS OF JAW 6 0.0002
673 BLOOD PRESSURE INCREASED 37 0.0002
674 SECOND PRIMARY MALIGNANCY 2 0.0002
675 HAEMODIALYSIS 2 0.0002
676 THROMBOSIS 19 0.0002
677 BUNDLE BRANCH BLOCK LEFT 1 0.0002
678 CARDIAC FAILURE CHRONIC 1 0.0002
679 ABSCESS LIMB 1 0.0002
680 ARRHYTHMIA 11 0.0002
681 CHILLS 27 0.0002
682 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
683 COLD SWEAT 4 0.0002
684 RENAL FAILURE 30 0.0002
685 BLOOD CREATINE INCREASED 1 0.0002
686 STEVENS-JOHNSON SYNDROME 5 0.0002
687 ORAL PAIN 5 0.0002
688 JAUNDICE 6 0.0002
689 ANAL INCONTINENCE 2 0.0002
690 HEPATIC ENZYME INCREASED 15 0.0002
691 HYPERGLYCAEMIA 8 0.0002
692 ABDOMINAL HERNIA 1 0.0002
693 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
694 PERICARDIAL EFFUSION 5 0.0002
695 MIDDLE INSOMNIA 4 0.0002
696 APPENDICITIS 2 0.0002
697 PLEURAL EFFUSION 13 0.0002
698 FLANK PAIN 2 0.0002
699 DYSPNOEA EXERTIONAL 8 0.0002
700 RENAL FAILURE ACUTE 9 0.0002
701 DYSPHAGIA 20 0.0002
702 CARDIAC TAMPONADE 1 0.0002
703 HYPERSENSITIVITY 39 0.0002
704 RED BLOOD CELL COUNT DECREASED 6 0.0002
705 URINARY RETENTION 7 0.0002
706 SLEEP APNOEA SYNDROME 4 0.0002
707 HYPERHIDROSIS 27 0.0002
708 HYPOTENSION 42 0.0002
709 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
710 PANCREATITIS 11 0.0002
711 APHAGIA 1 0.0002
712 PRESYNCOPE 5 0.0002
713 DYSPHONIA 12 0.0002
714 COELIAC DISEASE 2 0.0002
715 LIVER INJURY 5 0.0002
716 HEPATOMEGALY 2 0.0002
717 LIGAMENT SPRAIN 2 0.0002
718 DELIRIUM 7 0.0002
719 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
720 HYPERTENSION 42 0.0002
721 CONSTIPATION 43 0.0002
722 DRUG LEVEL DECREASED 2 0.0002
723 SUBARACHNOID HAEMORRHAGE 2 0.0002
724 HYPOPHAGIA 5 0.0002
725 LOSS OF CONSCIOUSNESS 25 0.0002
726 CEREBRAL ISCHAEMIA 1 0.0002
727 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
728 ACUTE MYELOID LEUKAEMIA 3 0.0002
729 EYE DISCHARGE 2 0.0002
730 CYANOSIS 3 0.0002
731 SYNCOPE 19 0.0002
732 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
733 ANORECTAL DISCOMFORT 1 0.0002
734 SENSORY DISTURBANCE 3 0.0002
735 COMPRESSION FRACTURE 1 0.0002
736 THROAT TIGHTNESS 5 0.0002
737 COLITIS 7 0.0002
738 ABDOMINAL PAIN UPPER 38 0.0002
739 PULMONARY THROMBOSIS 2 0.0002
740 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
741 DYSPEPSIA 18 0.0002
742 IMPAIRED HEALING 6 0.0002
743 ANGIOEDEMA 8 0.0002
744 FEELING COLD 5 0.0002
745 BLOOD UREA INCREASED 3 0.0002
746 WEIGHT DECREASED 50 0.0002
747 ANGIOPATHY 1 0.0002
748 NEPHROPATHY TOXIC 2 0.0002
749 UNDERDOSE 13 0.0002
750 PANCREATITIS ACUTE 4 0.0002
751 FISTULA 2 0.0002
752 STATUS EPILEPTICUS 2 0.0002
753 COLECTOMY 1 0.0002
754 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
755 DRUG INTERACTION 28 0.0002
756 BRONCHITIS 13 0.0002
757 GASTRIC DISORDER 6 0.0002
758 CATARACT OPERATION 1 0.0002
759 CARDIO-RESPIRATORY ARREST 7 0.0002
760 DIABETIC KETOACIDOSIS 4 0.0002
761 HEPATITIS C 2 0.0002
762 SEIZURE 19 0.0002
763 URINARY TRACT INFECTION 28 0.0002
764 GENERALISED OEDEMA 2 0.0002
765 PHARYNGITIS 2 0.0002
766 BACTERIAL INFECTION 3 0.0002
767 EPISTAXIS 12 0.0002
768 NERVOUS SYSTEM DISORDER 5 0.0002
769 HEPATIC CIRRHOSIS 3 0.0002
770 DERMATITIS ALLERGIC 2 0.0002
771 BLEPHAROSPASM 1 0.0002
772 BRAIN OEDEMA 2 0.0002
773 NODULE 2 0.0002
774 BRADYPHRENIA 1 0.0002
775 INFLUENZA 17 0.0002
776 INFECTION 22 0.0002
777 ORAL CANDIDIASIS 2 0.0002
778 SARS-COV-2 TEST POSITIVE 2 0.0002
779 FUNGAL INFECTION 5 0.0001
780 DRY SKIN 20 0.0001
781 ILL-DEFINED DISORDER 9 0.0001
782 HYPOAESTHESIA 22 0.0001
783 RIB FRACTURE 3 0.0001
784 SKIN LESION 4 0.0001
785 GASTROINTESTINAL DISORDER 13 0.0001
786 HAEMOPTYSIS 4 0.0001
787 LUNG DISORDER 7 0.0001
788 SKIN REACTION 2 0.0001
789 RETCHING 3 0.0001
790 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
791 BRONCHOSPASM 2 0.0001
792 PANCREATIC CARCINOMA 4 0.0001
793 HYPOKINESIA 2 0.0001
794 ACUTE MYOCARDIAL INFARCTION 4 0.0001
795 WHEEZING 8 0.0001
796 DRUG INTOLERANCE 13 0.0001
797 BLOOD POTASSIUM DECREASED 4 0.0001
798 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
799 AORTIC ANEURYSM 1 0.0001
800 COVID-19 23 0.0001
801 ACIDOSIS 1 0.0001
802 SKIN EXFOLIATION 11 0.0001
803 PNEUMONIA 42 0.0001
804 MUSCULOSKELETAL CHEST PAIN 2 0.0001
805 FEMUR FRACTURE 4 0.0001
806 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
807 DYSPNOEA 73 0.0001
808 RASH 56 0.0001
809 APNOEA 1 0.0001
810 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
811 ARTHRITIS 10 0.0001
812 CHEST DISCOMFORT 13 0.0001
813 PRURITUS 48 0.0001
814 BLOOD DISORDER 1 0.0001
815 MUSCLE TIGHTNESS 2 0.0001
816 DRUG LEVEL INCREASED 2 0.0001
817 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
818 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
819 CANDIDA INFECTION 2 0.0001
820 CATARACT 7 0.0001
821 SCAR 2 0.0001
822 BACK PAIN 27 0.0001
823 SPEECH DISORDER 6 0.0001
824 TREMOR 19 0.0001
825 HEART RATE DECREASED 4 0.0001
826 LYMPHOCYTE COUNT DECREASED 2 0.0001
827 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
828 EAR INFECTION 3 0.0001
829 PAIN OF SKIN 3 0.0001
830 RESPIRATORY FAILURE 8 0.0001
831 RESTLESSNESS 4 0.0001
832 CARDIAC ARREST 9 0.0001
833 RHINORRHOEA 7 0.0001
834 FLUSHING 11 0.0001
835 CONJUNCTIVITIS 2 0.0001
836 AGRANULOCYTOSIS 2 0.0001
837 SWELLING FACE 7 0.0001
838 HEPATIC STEATOSIS 2 0.0001
839 BLISTER 6 0.0001
840 ARTERIOSCLEROSIS 1 0.0001
841 CONVULSION 6 0.0001
842 RASH ERYTHEMATOUS 5 0.0001
843 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
844 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
845 LIVER FUNCTION TEST ABNORMAL 3 0.0001
846 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
847 AUTOIMMUNE DISORDER 1 0.0001
848 MENORRHAGIA 2 0.0001
849 PRODUCT USE ISSUE 19 0.0001
850 INJURY 7 0.0001
851 RHEUMATOID ARTHRITIS 11 0.0001
852 HALLUCINATION, VISUAL 2 0.0001
853 OSTEOARTHRITIS 4 0.0001
854 PALPITATIONS 11 0.0001
855 HOT FLUSH 7 0.0001
856 ACNE 7 0.0001
857 CHOLELITHIASIS 3 0.0001
858 ASPIRATION 1 0.0001
859 STAPHYLOCOCCAL INFECTION 3 0.0001
860 TACHYCARDIA 8 0.0001
861 TOOTH DISORDER 2 0.0001
862 NEOPLASM MALIGNANT 6 0.0001
863 HEPATOTOXICITY 2 0.0001
864 NECK PAIN 5 0.0001
865 GLOSSODYNIA 2 0.0001
866 PULMONARY OEDEMA 4 0.0001
867 COUGH 25 0.0001
868 FLATULENCE 5 0.0001
869 NEPHROLITHIASIS 4 0.0001
870 ADVERSE EVENT 8 0.0001
871 ABDOMINAL DISTENSION 9 0.0001
872 CONDITION AGGRAVATED 26 0.0001
873 LYMPHADENOPATHY 3 0.0001
874 BLOOD IRON DECREASED 1 0.0001
875 CEREBRAL HAEMORRHAGE 3 0.0001
876 DEATH 72 0.0001
877 ATRIAL FIBRILLATION 8 0.0001
878 CHEST PAIN 15 0.0001
879 ABASIA 2 0.0001
880 HEART RATE INCREASED 8 0.0001
881 ABDOMINAL PAIN LOWER 2 0.0001
882 GASTRIC CANCER 2 0.0001
883 INSOMNIA 21 0.0001
884 CARDIOVASCULAR DISORDER 2 0.0001
885 INFLAMMATION 4 0.0001
886 RASH GENERALISED 2 0.0001
887 AMNESIA 5 0.0001
888 ALOPECIA 15 0.0001
889 BEDRIDDEN 1 0.0001
890 ANKYLOSING SPONDYLITIS 1 0.0001
891 DISORIENTATION 3 0.0001
892 ADVERSE REACTION 1 0.0001
893 FATIGUE 58 0.0001
894 AKATHISIA 1 0.0001
895 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
896 RESPIRATORY ARREST 2 0.0001
897 ROAD TRAFFIC ACCIDENT 3 0.0001
898 ANGINA PECTORIS 2 0.0001
899 DEVICE DISLOCATION 3 0.0001
900 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
901 APATHY 1 0.0001
902 AGITATION 5 0.0001
903 ARTHRALGIA 28 0.0001
904 RESPIRATORY DISORDER 2 0.0001
905 APHASIA 2 0.0001
906 THERAPEUTIC RESPONSE DECREASED 4 0.0001
907 PERIPHERAL SWELLING 10 0.0001
908 MYALGIA 11 0.0001
909 ANKLE FRACTURE 1 0.0001
910 HEAD INJURY 2 0.0001
911 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
912 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
913 ASTHMA 7 0.0001
914 BLOOD POTASSIUM INCREASED 1 0.0001
915 EXPIRED PRODUCT ADMINISTERED 2 0.0001
916 VIRAL INFECTION 2 0.0001
917 COAGULOPATHY 1 0.0001
918 NASOPHARYNGITIS 11 0.0001
919 CELLULITIS 3 0.0001
920 CIRCULATORY COLLAPSE 1 0.0001
921 HAEMORRHAGE 6 0.0001
922 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
923 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
924 ACCIDENTAL OVERDOSE 2 0.0001
925 DYSURIA 2 0.0001
926 ARTHROPATHY 3 0.0001
927 BLOOD SODIUM DECREASED 1 0.0001
928 CHRONIC KIDNEY DISEASE 4 0.0001
929 MIGRAINE 5 0.0001
930 LETHARGY 3 0.0001
931 OVERDOSE 11 0.0001
932 PAIN IN EXTREMITY 15 0.0001
933 BLOOD PRESSURE ABNORMAL 1 0.0001
934 IRRITABILITY 3 0.0000
935 SOMNOLENCE 10 0.0000
936 DRY MOUTH 4 0.0000
937 DYSKINESIA 2 0.0000
938 WEIGHT INCREASED 11 0.0000
939 BODY TEMPERATURE INCREASED 1 0.0000
940 POLLAKIURIA 2 0.0000
941 URTICARIA 8 0.0000
942 GAIT DISTURBANCE 9 0.0000
943 ANXIETY 13 0.0000
944 PAIN 28 0.0000
945 FALL 15 0.0000
946 COLITIS ULCERATIVE 2 0.0000
947 THROAT IRRITATION 2 0.0000
948 CHROMATURIA 1 0.0000
949 MUSCULAR WEAKNESS 5 0.0000
950 SKIN DISCOLOURATION 2 0.0000
951 OROPHARYNGEAL PAIN 4 0.0000
952 RENAL DISORDER 2 0.0000
953 COGNITIVE DISORDER 2 0.0000
954 HEADACHE 25 0.0000
955 DIABETES MELLITUS 3 0.0000
956 THERAPY CESSATION 2 0.0000
957 ECZEMA 2 0.0000
958 MUSCLE SPASMS 7 0.0000
959 DIZZINESS 19 0.0000
960 TREATMENT NONCOMPLIANCE 2 0.0000
961 INFLUENZA LIKE ILLNESS 3 0.0000
962 ABDOMINAL DISCOMFORT 6 0.0000
963 CEREBROVASCULAR ACCIDENT 6 0.0000
964 BONE PAIN 2 0.0000
965 VERTIGO 2 0.0000
966 BLOOD GLUCOSE INCREASED 6 0.0000
967 CONFUSIONAL STATE 5 0.0000
968 TOXICITY TO VARIOUS AGENTS 5 0.0000
969 VISION BLURRED 4 0.0000
970 NO ADVERSE EVENT 5 0.0000
971 DRUG INEFFECTIVE 35 0.0000
972 FEELING ABNORMAL 6 0.0000
973 PRODUCT DOSE OMISSION ISSUE 7 0.0000
974 BALANCE DISORDER 2 0.0000
975 DEVICE ISSUE 2 0.0000
976 ADVERSE DRUG REACTION 2 0.0000
977 BLOOD CHOLESTEROL INCREASED 1 0.0000
978 CONTUSION 2 0.0000
979 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
980 SINUSITIS 2 0.0000
981 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
982 BLADDER CANCER 1 0.0000
983 JOINT SWELLING 2 0.0000
984 INJECTION SITE ERYTHEMA 2 0.0000
985 MEMORY IMPAIRMENT 2 0.0000
986 BURNING SENSATION 1 0.0000
987 INCORRECT DOSE ADMINISTERED 3 0.0000
988 CARDIAC FAILURE CONGESTIVE 1 0.0000
989 MYOCARDIAL INFARCTION 2 0.0000
990 CARDIAC DISORDER 1 0.0000